Survival analysis showed that high EPHB4 expression reduced both overall and event‐free survival probabilities of NB patients (P = 1.0 × 10−3 and P = 5.1 × 10−3, respectively) (Figure 1C). The gene discussed is EPHB4; the disease is neuroblastoma.